(Updated to include HSBC's commentary) HSBC upgraded Eli Lilly (LLY) to hold from reduce, noting
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Update: HSBC Upgrades Eli Lilly to Hold From Reduce, Adjusts Price Target to $700 From $675
Published 2 months ago
Aug 27, 2025 at 1:33 PM
Positive
Auto